Let’s Talk Use Cases: Where AI Accelerates Early Commercialization—and Where It Falls Short

Session details:

Artificial Intelligence (AI) promises to revolutionize biopharma commercialization. But how realistic are those promises—especially in early-stage commercialization?

This session explores where AI can meaningfully accelerate insight generation, optimize stakeholder engagement, and drive brand strategy—and where human judgment and qualitative inputs remain irreplaceable.